Login to Your Account

MHRA Lifts Hold on MediGene's RhuDex in RA; New Trial Likely

By Cormac Sheridan

Wednesday, October 7, 2009
Almost 15 months after halting a Phase I trial of RhuDex following the death of a trial volunteer in Edinburgh, Scotland, the UK's Medicines and Healthcare products Regulatory Agency has lifted the clinical hold on the study. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription